CO [China Cord Blood] SC 13G: (Original Filing)

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

By | 2016-02-29T14:51:33+00:00 April 27th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G: *The remainder of this cover page shall be

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

By | 2016-02-29T14:52:16+00:00 April 27th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

ZX [China Zenix Auto International] 6-K: (Original Filing)

[China Zenix Filed Annual Report on Form 20-F for 2011 ZHANGZHOU, China, April 26, 2012 – China Zenix Auto International Limited About China Zenix Auto International Limited China Zenix Auto International Limited is the largest commercial vehicle wheel manufacturer in China in both the aftermarket and OEM market by sales volume. With a large intellectual property portfolio, the Company offers]

By | 2016-02-29T21:11:39+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, ZX|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8: (Original Filing)

[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]

By | 2016-03-01T04:44:36+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8:

[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]

By | 2016-03-01T04:45:08+00:00 April 27th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 20-F: (Original Filing)

[FORM 20-F o OR ý For the Fiscal Year Ended December 31, 2011 OR o For the transition period from to OR o UTStarcom Holdings Corp. N/A Cayman Islands (Jurisdiction of incorporation or organization) 52-2 Building, BDA International Enterprise Avenue Jing Ou-Yang None Title of Each Class Name of Exchange on which Registered Ordinary Shares, $0.00125 par value The NASDAQ] [EX-4.3 2 a2209029zex-4_3.htm EX-4.3] [SUBSIDIARIES OF UTSTARCOM HOLDINGS CORP. Name Place of Incorporation Proportion of UTStarcom, Inc.(1) U.S.A 100 % UTStarcom International Products, Inc. U.S.A 100 % UTStarcom International Services, Inc. U.S.A 100 % IssanniCommnications, Inc. U.S.A 100 % UTStarcom (China), Co., Ltd(1) China 100 % UTStarcom Telecom Co., Ltd(1) China 100 % UTStarcom (Chongqing) Telecom Co., Ltd. China] [CERTIFICATION I, Jack Lu, certify that: 1. I have reviewed this annual report on Form 20-F of UTStarcom Holdings Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Jin Jiang, certify that: 1. I have reviewed this annual report on Form 20-F of UTStarcom Holdings Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [(1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: April 27, 2012 Jack Lu President and Chief Executive Officer EX-13.1 6 a2209029zex-13_1.htm EX-13.1] [(1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: April 27, 2012 Jin Jiang Senior Vice President and Chief Financial Officer EX-13.2 7 a2209029zex-13_2.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-108817, 333-84710, 333-44548, 333-60150, 333-120564, 333-127850, 333-136551 and 333-161639) of UTStarcom Holdings Corp. of our report dated April 27, 2012 relating to the consolidated financial statements, financial statement schedules and the effectiveness of internal control over financial]

By | 2016-03-01T12:28:37+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments
Skip to toolbar